Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
As of close of business last night, Gossamer Bio Inc’s stock clocked out at $2.08, up 6.12% from its previous closing price of $1.96. In other words, the price has increased by $6.12 from its previous closing price. On the day, 3.9 million shares were traded. GOSS stock price reached its highest trading level at $2.17 during the session, while it also had its lowest trading level at $2.03.
Ratios:
To gain a deeper understanding of GOSS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.71 and its Current Ratio is at 5.71.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Scotiabank on July 14, 2025, initiated with a Sector Outperform rating and assigned the stock a target price of $11.
On June 25, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $9.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GOSS now has a Market Capitalization of 472788128 and an Enterprise Value of 417641440. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.79. Its current Enterprise Value per Revenue stands at 3.352 whereas that against EBITDA is -7.707.
Stock Price History:
The Beta on a monthly basis for GOSS is 1.98, which has changed by 1.3636363 over the last 52 weeks, in comparison to a change of 0.16821623 over the same period for the S&P500. Over the past 52 weeks, GOSS has reached a high of $2.18, while it has fallen to a 52-week low of $0.66. The 50-Day Moving Average of the stock is 49.91%, while the 200-Day Moving Average is calculated to be 90.93%.
Shares Statistics:
It appears that GOSS traded 2.28M shares on average per day over the past three months and 3665940 shares per day over the past ten days. A total of 227.22M shares are outstanding, with a floating share count of 182.66M. Insiders hold about 19.64% of the company’s shares, while institutions hold 58.85% stake in the company. Shares short for GOSS as of 1752537600 were 18122038 with a Short Ratio of 7.95, compared to 1749772800 on 11076527. Therefore, it implies a Short% of Shares Outstanding of 18122038 and a Short% of Float of 8.49.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The current market rating for Gossamer Bio Inc (GOSS) reflects the collective analysis of 9.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.18, with high estimates of -$0.15 and low estimates of -$0.21.
Analysts are recommending an EPS of between -$0.61 and -$0.8 for the fiscal current year, implying an average EPS of -$0.69. EPS for the following year is -$0.49, with 9.0 analysts recommending between -$0.11 and -$0.81.
Revenue Estimates
A total of 10 analysts have provided revenue estimates for GOSS’s current fiscal year. The highest revenue estimate was $59.8M, while the lowest revenue estimate was $9.89M, resulting in an average revenue estimate of $28.03M. In the same quarter a year ago, actual revenue was $114.7M
